Edenbridge Pharmaceuticals, LLC
Doing business as Dexcel Pharma USA
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersParsippany, NJ
US patents1
SAM.gov UEIFELSKZLP49R3
CAGE code5BXS8
Incorporated inDE
- marketing
- Generic Products
- Branded Products
- rare diseases
- multiple myeloma
- Gaucher disease
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
1 US patent granted MAY 5, 2020.
Pharmaceuticals 1
- Finished pharmaceutical dosage form of a methenamine salt such as methenamine mandelateUS 10,639,312 · granted MAY 5, 2020
Granted to Edenbridge Pharmaceuticals, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Edenbridge Pharmaceuticals, LLC | Parsippany | NJ | — | UNVERIFIED |
| Edenbridge Pharmaceuticals, LLC | Parsippany | NJ | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.


